Stay updated on Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial
Sign up to get notified when there's something new on the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page.

Latest updates to the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page
- Check3 days agoChange DetectedNo additions or deletions were reported in the provided changes, so the page content remains unchanged. The page describes the Study Details for NCT04548791, a Phase 1/2 trial of Marzeptacog Alfa (Activated) in inherited bleeding disorders.SummaryDifference0.2%

- Check10 days agoChange DetectedThe page's revision indicator was updated from Revision: v3.6.4 to Revision: v3.6.5, representing a software version update. This change updates the site's metadata without altering the study details or content.SummaryDifference0.1%

- Check17 days agoChange DetectedNo additions or deletions were detected; the page content remains unchanged.SummaryDifference0.2%

- Check25 days agoChange DetectedNo textual changes were reported for the study page. The content appears unchanged based on the given data.SummaryDifference0.1%

- Check32 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, marking a minor update to the revision history of the study page. This update does not modify any study data or user-facing information.SummaryDifference0.2%

- Check39 days agoChange DetectedNo additions or deletions are listed. The page content is unchanged.SummaryDifference0.1%

Stay in the know with updates to Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page.